Home/Pipeline/Saroglitazar

Saroglitazar

Diabetic Dyslipidemia

ApprovedCommercial

Key Facts

Indication
Diabetic Dyslipidemia
Phase
Approved
Status
Commercial
Company

About Zydus Lifesciences

Zydus Lifesciences Limited, formerly Cadila Healthcare, is a leading Indian multinational pharmaceutical company founded in 1952. The company operates across the entire pharmaceutical value chain with a strong presence in generic drugs, biosimilars, and consumer healthcare products. With manufacturing facilities in India and the US, Zydus serves markets globally including the United States, Europe, and emerging markets, maintaining a robust pipeline of over 300 molecules under development.

View full company profile